The future of evidence-based medicine for traditional Chinese medicine and health technology assessment

Jian-ping Liu , Nicola Robinson

Evidence-Based Chinese Medicine and Technology Assessment ›› 2025, Vol. 1 ›› Issue (1) : 9570004

PDF (798KB)
Evidence-Based Chinese Medicine and Technology Assessment ›› 2025, Vol. 1 ›› Issue (1) :9570004 DOI: 10.26599/eCMTA.2025.9570004
Editorial
research-article
The future of evidence-based medicine for traditional Chinese medicine and health technology assessment
Author information +
History +
PDF (798KB)

Cite this article

Download citation ▾
Jian-ping Liu, Nicola Robinson. The future of evidence-based medicine for traditional Chinese medicine and health technology assessment. Evidence-Based Chinese Medicine and Technology Assessment, 2025, 1 (1) : 9570004 DOI:10.26599/eCMTA.2025.9570004

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Fung FY, Linn YC. Developing traditional Chinese medicine in the era of evidence-based medicine: current evidences and challenges. Evid Based Complement Alternat Med. 2015; 2015:425037.

[2]

Tian G, Zhao C, Zhang X, et al. Evidence-based traditional Chinese medicine research: Two decades of development, its impact, and breakthrough. J Evid Based Med. 2021; 14(1):65-74.

[3]

World Health Organization. Traditional, complementary and integrative medicine (TCI). https://www.who.int/teams/integrated-health-services/traditional-complementary-and-integrative-medicine/global-strategies. Accessed April 6, 2025.

[4]

Yuan L, Tian ZY, Liu B, Hong YY, Robinson N. Chinese guidelines on acupuncture for post-stroke dysphagia - quality assessment and evidence analysis. Evid Based Chin Med Technol Assess. 2025; 1:9570002.

[5]

He Y, Wen Q, Wang Y, et al. Establishing a regulatory science system for supervising the application of artificial intelligence for traditional Chinese medicine: a methodological framework. Evid Based Complement Alternat Med. 2022; 2022:9680203.

[6]

Sun X, Li L, Liu Y, et al. Assessing clinical effects of traditional Chinese medicine interventions: moving beyond randomized controlled trials. Front Pharmacol. 2021; 12:713071.

PDF (798KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉